Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy
European Journal of Surgical Oncology Dec 02, 2018
Lee YJ, et al. - Researchers analyzed the data of 103 patients with preoperative cancer antigen-125 (CA-125) normalization after neoadjuvant chemotherapy (NAC) at the Yonsei Cancer Hospital (2006–2017), to determine the prognostic significance of postoperative re-elevation of CA-125 levels in patients with ovarian cancer and preoperative normalization of CA-125 levels after NAC. Outcomes suggest no prognostic value of postoperative CA-125 re-elevation for patients with preoperative CA-125 normalization after NAC.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
